Display options
Cite
Wang C, Liao Q, Hu Y, et al. T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med. 2014;9(1):250-256doi: 10.3892/etm.2014.2046.
Wang, C., Liao, Q., Hu, Y., & Zhong, D. (2015). T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Experimental and therapeutic medicine, 9(1), 250-256. https://doi.org/10.3892/etm.2014.2046
Wang, Chenggong, et al. "T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis." Experimental and therapeutic medicine vol. 9,1 (2015): 250-256. doi: https://doi.org/10.3892/etm.2014.2046
Wang C, Liao Q, Hu Y, Zhong D. T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med. 2015 Jan;9(1):250-256. doi: 10.3892/etm.2014.2046. Epub 2014 Nov 04. PMID: 25452811; PMCID: PMC4247318.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2015 Jan;9(1):250-256. doi: 10.3892/etm.2014.2046. Epub 2014 Nov 04.

T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis.

Experimental and therapeutic medicine

Chenggong Wang, Qiande Liao, Yihe Hu, DA Zhong

Affiliations

  1. Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.

PMID: 25452811 PMCID: PMC4247318 DOI: 10.3892/etm.2014.2046

Abstract

Ankylosing spondylitis is a chronic inflammatory rheumatic disease, which is characterized by inflammation of the spine and the sacroiliac joints. To date, the disease etiology remains unclear. In the present study, the correlation of T lymphocyte subset changes with the progression of ankylosing spondylitis was investigated. A total of 55 patients with ankylosing spondylitis (22 severe and 23 mild cases) and 20 healthy individuals were selected. Firstly, the punctured cells in the lesions and the serum were collected, and the lymphocytes and the peripheral blood mononuclear cells were prepared. Secondly, quantitative PCR, ELISA and flow cytometry analyses were carried out to detect the levels of a series of immunoglobulins, complements, helper T cells, cytotoxic T cells, regulatory cells and cytokines. The expression levels of α-globulin, γ-globulin, immunoglobulin (Ig)G, IgA, IgM, serum complement C3, and complement C4 were found to be significantly increased in ankylosing spondylitis patients. In addition, the percentage of Th1 and Th17 cells was found to be significantly higher in the ankylosing spondylitis groups (mild and severe) compared with the healthy individuals. As a result, the Th1/Th2 and Th17/Treg ratios were significantly higher in patients with ankylosing spondylitis. In addition, T lymphocyte subset ratio imbalances contributed to an increased expression of immune mediators, including interferon (IFN)-γ and interleukin (IL)-17A. The mRNA and protein expression levels of IFN-γ and IL-17A were found to be higher in the ankylosing spondylitis groups compared with the control group. The present study provided further evidence on the function and underlying mechanism of T lymphocyte subsets, which may be useful in the diagnosis and treatment of ankylosing spondylitis.

Keywords: T lymphocyte subsets; ankylosing spondylitis; cytokines; imbalance; inflammation

References

  1. J Pediatr. 1982 Apr;100(4):521-8 - PubMed
  2. Biochem Biophys Res Commun. 2013 Oct 4;439(4):471-6 - PubMed
  3. Trends Immunol. 2011 Dec;32(12):603-11 - PubMed
  4. Cell Oncol (Dordr). 2012 Oct;35(5):335-43 - PubMed
  5. Scand J Rheumatol. 2005 Jul-Aug;34(4):251-9 - PubMed
  6. Altern Med Rev. 2003 Aug;8(3):223-46 - PubMed
  7. Eur J Dermatol. 2009 Jan-Feb;19(1):69-71 - PubMed
  8. Ann Rheum Dis. 2000 Dec;59(12):985-94 - PubMed
  9. Arthritis Res Ther. 2011 Feb 21;13(1):R29 - PubMed
  10. Arthritis Rheum. 1984 Apr;27(4):361-8 - PubMed
  11. Ann Rheum Dis. 2000 Apr;59(4):263-8 - PubMed
  12. Infect Immun. 2012 Dec;80(12):4271-80 - PubMed
  13. Br J Rheumatol. 1997 Jul;36(7):766-71 - PubMed
  14. Arthritis Rheum. 2005 Mar;52(3):892-901 - PubMed
  15. Blood Cancer J. 2013 Sep 13;3:e148 - PubMed
  16. J Immunol. 2009 Dec 1;183(11):7161-8 - PubMed
  17. J Laryngol Otol. 2000 Feb;114(2):154-7 - PubMed
  18. Lancet. 2002 Apr 6;359(9313):1187-93 - PubMed
  19. Przegl Epidemiol. 2013;67(1):17-22, 105-9 - PubMed
  20. Arthritis Rheum. 2000 Jun;43(6):1346-52 - PubMed
  21. Immunol Rev. 2008 Dec;226:57-79 - PubMed
  22. JAMA. 1977 Jun 13;237(24):2613-4 - PubMed
  23. Spine (Phila Pa 1976). 1989 Aug;14 (8):803-7 - PubMed
  24. Arthritis Rheum. 2009 Mar;60(3):717-27 - PubMed
  25. Cell. 1980 Apr;19(4):821-7 - PubMed
  26. Lancet. 2007 Apr 21;369(9570):1379-90 - PubMed
  27. Nature. 1999 Oct 14;401(6754):708-12 - PubMed
  28. Arthritis Rheum. 1997 Oct;40(10):1823-8 - PubMed
  29. Cancers (Basel). 2014 Jan 27;6(1):211-25 - PubMed
  30. Nat Med. 2007 Feb;13(2):139-45 - PubMed
  31. Clin Microbiol Rev. 1996 Oct;9(4):532-62 - PubMed
  32. Arthritis Rheum. 1984 Mar;27(3):241-9 - PubMed
  33. Chin Med J (Engl). 2009 Aug 5;122(15):1784-9 - PubMed
  34. Clin Dev Immunol. 2012;2012:808724 - PubMed
  35. Arthritis Res Ther. 2005;7(6):R1412-20 - PubMed

Publication Types